|
⚲
|
| Keyboard |
| Doyle William F
✚
|
|
|---|---|
| CIK # | 0001194459 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001194459] | |
| 4 | [0001194459] | |
| SC 13G | [0001194459] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Doyle William F | Novocure Ltd | [2016-02-12] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Doyle William F | |
| Prokidney Corp | |
| NovoCure Ltd | |
| Elanco Animal Health Inc | |
| Minerva Neurosciences Inc | |
| OptiNose Inc | |
| WFD Ventures Fund II LP | |
| Zoetis Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-03 | Grant | 200,284 | $0.00 | |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-03 | Grant | 200,000 | $0.00 | |
|
NovoCure Ltd NVCR
Stock Option (Right to Buy) · derivative
|
2026-03-03 | Grant | 30,072 | $0.00 | |
|
NovoCure Ltd NVCR
Stock Option (Right to Buy) · derivative
|
2026-03-03 | Grant | 258,445 | $0.00 | |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-03 | Sell | 50,557 | $12.79 | 646,624 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-03 | Sell | 21,330 | $13.43 | 286,462 |
|
Prokidney Corp PROK
Director stock option (right to buy) · derivative
|
2025-05-29 | Grant | 125,862 | $0.00 | |
|
Elanco Animal Health Inc ELAN
Common Stock
|
2024-11-29 | Grant | 18,169 | $0.00 | |
|
Prokidney Corp PROK
Director stock option (right to buy) · derivative
|
2024-05-30 | Grant | 62,558 | $0.00 | |
|
Elanco Animal Health Inc ELAN
Common Stock
|
2024-05-21 | Buy | 15,000 | $16.98 | 254,700 |
|
Elanco Animal Health Inc ELAN
Common Stock
|
2024-03-08 | Buy | 15,000 | $16.30 | 244,500 |
|
Elanco Animal Health Inc ELAN
Common Stock
|
2023-11-30 | Grant | 20,374 | $0.00 | |
|
Prokidney Corp PROK
Director Stock Option (right to buy) · derivative
|
2023-06-29 | Grant | 48,128 | $0.00 | |
|
Elanco Animal Health Inc ELAN
Common Stock
|
2022-11-30 | Grant | 18,649 | $0.00 | |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2022-08-02 | Sell | 837 | $69.66 | 58,305 |
|
Prokidney Corp PROK
Common Units in ProKidney LP · derivative
|
2022-07-11 | Grant | 1,514,326 | $0.00 | |
|
Prokidney Corp PROK
Class B Ordinary Shares · derivative
|
2022-07-11 | Grant | 1,514,326 | $0.00 | |
|
Minerva Neurosciences Inc NERV
Stock Option (right to buy) · derivative
|
2022-06-10 | Grant | 2,500 | $0.00 | |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2022-03-08 | Sell | 2,385 | $70.10 | 167,188 |
|
NovoCure Ltd NVCR
Options to Buy Ordinary Shares · derivative
|
2022-03-03 | Grant | 14,581 | $80.59 | 1,175,083 |
| showing 20 of 178 most recent transactions | |||||